R&D / Biosciences · Registry of Record
Armamentarium
The Directorate's unified catalogue — every drug, implant, gene therapy, pathogen, and subject line we make, distribute, and hold, from the over-the-counter shelf to the classified assets in the BSL-4 Vault. Filter by type, channel, BCL grade, disclosure class, function, or approval, or search by name. — records on file; some marketed, some never acknowledged.

Marketed
Halo Focus
HALO-Gen3 cortical mesh
implant clinic
implant
BCL-2
PAN-AST-0001 · FDA-Approved

Marketed
Halo Calm
HALO-Gen3 limbic regulator
implant clinic
implant
BCL-2
PAN-AST-0002 · FDA-Approved

Marketed
Halo Connect
HALO-Gen3 social cortex link
implant clinic
implant
BCL-2
PAN-AST-0003 · FDA-Approved

Marketed
Immunary-7
mRNA platform HX-mR7
vaccination program
vaccine
BCL-2
PAN-AST-0011 · Emergency-Use

Marketed
Rejuvan
AAV regenerative vector HX-RV2
hospital
gene-therapy
BCL-2
PAN-AST-0013 · FDA-Approved

Marketed
ClariVision
retinal photonic implant HX-RV
implant clinic
device
BCL-1
PAN-AST-0014 · FDA-Approved

Marketed
NeuroSync Band
wearable EEG monitor HX-W1
retail pharmacy
device
BCL-1
PAN-AST-0015 · FDA-Approved

Marketed
Vitalis Daily
micronutrient blend HX-MN
food supply
drug
BCL-1
PAN-AST-0016 · Not Evaluated

Marketed
Mendaril
broad-spectrum antibiotic HX-220
retail pharmacy
drug
BCL-1
PAN-AST-0018 · FDA-Approved

Marketed
FluShield-X
seasonal vaccine HX-FS
vaccination program
vaccine
BCL-2
PAN-AST-0019 · Emergency-Use

Marketed
Pediavax-9
pediatric combination vaccine HX-P9
vaccination program
vaccine
BCL-2
PAN-AST-0020 · FDA-Approved

Marketed
Cogniva
cholinesterase inhibitor HX-512c
prescription
drug
BCL-2
PAN-AST-0025 · FDA-Approved

Marketed
Halo Junior
HALO-Gen3 pediatric mesh
implant clinic
implant
BCL-2
PAN-AST-0026 · FDA-Approved

Marketed
Gastrelle
proton-pump inhibitor HX-210
retail pharmacy
drug
BCL-1
PAN-AST-0029 · FDA-Approved

Marketed
DermaSeal
topical gene vector HX-DV
retail pharmacy
gene-therapy
BCL-1
PAN-AST-0030 · FDA-Approved

Marketed
Halo Elder
HALO-Gen3 geriatric monitor
implant clinic
implant
BCL-2
PAN-AST-0032 · FDA-Approved

Marketed
VaxiGuard Universal
pan-pathogen platform HX-UV
vaccination program
vaccine
BCL-2
PAN-AST-0036 · Emergency-Use

In-Trial
Halo Sovereign
HALO-Gen4 executive mesh
clinical trial
implant
BCL-3
PAN-AST-0037 · Investigational

In-Trial
Mnemosyne
reconsolidation agent HX-RC
clinical trial
drug
BCL-3
PAN-AST-0038 · Investigational

In-Trial
Perenne
telomere vector HX-TL
clinical trial
gene-therapy
BCL-3
PAN-AST-0039 · Investigational

In-Trial
Germline-A1
heritable edit vector HX-GL
clinical trial
gene-therapy
BCL-3
PAN-AST-0042 · Investigational

In-Trial
NanoSentinel
in-vivo nanobot HX-NS
clinical trial
nanobio
BCL-3
PAN-AST-0043 · Investigational

In-Trial
Calmara XR
extended anxiolytic HX-150x
clinical trial
drug
BCL-2
PAN-AST-0044 · Investigational

In-Trial
Halo Dream
HALO-Gen4 sleep architect
clinical trial
implant
BCL-2
PAN-AST-0046 · Investigational

In-Trial
ImmunoForge
engineered immunity vector HX-IF
clinical trial
gene-therapy
BCL-3
PAN-AST-0047 · Investigational

In-Trial
BioMarker-Live
continuous biometric injectable HX-BL
clinical trial
nanobio
BCL-2
PAN-AST-0048 · Investigational

Investigational
Equanil-9
ambient mood agent HX-E9
classified
drug
BCL-3
PAN-AST-0049 · Investigational

Investigational
Tractamine
suggestibility enhancer HX-SG
classified
drug
BCL-3
PAN-AST-0050 · Black Program

Investigational
Halo Override
HALO restricted firmware OV-0
classified
implant
BCL-4
PAN-AST-0051 · Black Program

Investigational
Fecundyne
covert fertility suppressant HX-FS9
classified
drug
BCL-3
PAN-AST-0053 · Black Program

Investigational
Concordance
crowd-synchrony aerosol HX-CN
classified
nanobio
BCL-3
PAN-AST-0054 · Black Program

Investigational
Verdict
compliance conditioner HX-VD
classified
drug
BCL-3
PAN-AST-0056 · Black Program

Black-Label
Pax Aerosol CA-9
mass-compliance aerosol CA-9
aerosol dispersal
drug
BCL-4
PAN-AST-0057 · Black Program

Black-Label
Loyalty Firmware L-0
HALO loyalty conditioning L-0
classified
implant
BCL-4
PAN-AST-0059 · Black Program

Black-Label
Sterivax
covert sterilant vaccine HX-SV
vaccination program
vaccine
BCL-4
PAN-AST-0060 · Black Program

Black-Label
Somnus Gas
mass sedation aerosol HX-SM
aerosol dispersal
drug
BCL-4
PAN-AST-0061 · Black Program

Black-Label
Veritas Serum
interrogation agent HX-VR
classified
drug
BCL-3
PAN-AST-0062 · Black Program

Black-Label
Bliss-7
euphoric pacifier HX-B7
aerosol dispersal
drug
BCL-3
PAN-AST-0064 · Black Program

Black-Label
Halo Sentinel
HALO covert surveillance build
classified
implant
BCL-4
PAN-AST-0065 · Black Program

Black-Label
Vector Mosquito
gene-drive delivery insect HX-VM
classified
nanobio
BCL-3
PAN-AST-0066 · Black Program

Black-Label
Null Compound
deniable cardiotoxin HX-NL
classified
drug
BCL-4
PAN-AST-0067 · Black Program

Black-Label
Tranquil Water
municipal sedation program HX-TW
water supply
drug
BCL-3
PAN-AST-0068 · Emergency-Use

Classified
Strain Theta
engineered respiratory agent ENG-Θ
classified
pathogen
BCL-4
PAN-AST-0069 · Black Program

Classified
Strain Theta-Vax
paired countermeasure ENG-ΘV
classified
vaccine
BCL-4
PAN-AST-0070 · Black Program

Classified
Gene-Drive Kill-Switch
population lethality drive ENG-KS
classified
gene-therapy
BCL-4
PAN-AST-0071 · Black Program

Classified
Subject Line CV-1
enhanced cohort CV-1
classified
subject-line
BCL-4
PAN-AST-0072 · Black Program

Classified
Subject Line CV-9 (Lazarus)
regeneration cohort CV-9
classified
subject-line
BCL-4
PAN-AST-0073 · Black Program

Classified
PANACEA Seed
progenitor cell line PSL-0
classified
subject-line
BCL-4
PAN-AST-0074 · Black Program

Classified
Chimera-3
multi-vector engineered agent ENG-C3
classified
pathogen
BCL-4
PAN-AST-0075 · Black Program

Classified
Whisper
neural read-write aerosol HX-WS
classified
nanobio
BCL-4
PAN-AST-0076 · Black Program

Classified
The Ledger
continuity genomic archive CGA
classified
subject-line
BCL-4
PAN-AST-0077 · Black Program




























